HEC 116094
Alternative Names: HEC-116094Latest Information Update: 28 Sep 2024
At a glance
- Originator Sunshine Lake Pharma
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Sep 2024 No recent reports of development identified for phase-I development in Influenza-virus-infections(In volunteers, In adults) in China
- 29 Jul 2021 Preclinical trials in Influenza virus infections in China, prior to July 2021 (unspecified route)
- 29 Jul 2021 Sunshine Lake Pharma plans a phase I trial for Influenza virus infection (In volunteers) in China, in July 2021 (NCT04982913)